| Document |
Document Title |
|
WO/2013/086460 |
A photoacid compound comprising a light absorbing moiety attaching a payload moiety through a linker, in which the linker comprises a geminal dialkyl linked to a carbonyl group attaching the payload moiety, and the linker is configured t...
|
|
WO/2013/078372 |
In an aspect, the invention relates to compositions, methods, and kits for inhibiting or preventing skeletal muscle atrophy or inducing muscle hypertrophy by providing to an animal an effective amount of a composition comprising a Gadd45...
|
|
WO/2013/028289 |
Described herein are oxygen scavengers, oxygen scavenging polymeric compositions, and oxygen scavenging articles. The polymeric compositions comprising the oxygen scavengers may have utility in packaging, sealing, wrapping, and storing o...
|
|
WO/2013/007712 |
A process for the preparation of a compound of formula (I): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
|
|
WO/2012/117976 |
Provided are a method for producing an alicyclic carboxylic acid by hydrogenation of the aromatic ring of an aromatic carboxylic acid, wherein a catalyst containing ruthenium and palladium is used as the catalyst, and a catalyst supporti...
|
|
WO/2012/116238 |
The present disclosure is directed to compositions and methods for formulating a pharmaceutical dosage form by forming a composition comprising acetyl-11-keto-β- boswellic acid, diindolylmethane, or curcumin with one or more pharmaceuti...
|
|
WO/2012/086409 |
Disclosed is a mixture of regioisomers of dehydroabietic acid derivatives, which comprises at least two dehydroabietic acid derivatives each represented by general formula (I) and independently selected from the group consisting of methy...
|
|
WO/2012/080647 |
The invention relates to a continuous method for the carbonylation of an (R1R3)C - X alcohol in acid, where: R1 and R3 are radicals bonded to the carbon atom by means of a single covalent bond, or an aliphatic cyclic compound that integr...
|
|
WO/2012/082727 |
The present invention relates to polyamides prepared from benzene, cyclohexene and cyclohexane compounds having amide groups at the 1 and 4 positions and optionally the 2 position and diamines, such as 1,2-ethylene diamine, 1,4-diaminobu...
|
|
WO/2012/060347 |
[Problem] To provide an environmentally friendly organic hybrid type catalyst for achieving oxidation reaction of alcohols. [Solution] An organic hybrid type catalyst which is a 2,2,6,6-tetramethylpyridine-1-oxyl derivative represented b...
|
|
WO/2012/054400 |
A method is disclosed for the recovery of an organic acid from a dilute salt solution in which the cation of the salt forms an insoluble carbonate salt. An amine, C02 and a water immiscible solvent are introduced to the solution to form ...
|
|
WO/2012/035017 |
A process for the preparation of a compound of formula (I) which are useful as intermediates in the preparation of pharmaceutically active compounds.
|
|
WO/2011/162350 |
Provided are: a process for producing a high-quality aqueous solution of a diamine dicarboxylic acid salt by simple and easy steps; and a process for producing a polyamide. The process for producing a high-quality aqueous solution of a d...
|
|
WO/2011/151840 |
The invention relates to Boswellia derived fraction selected from non-acidic Boswellia low polar gum resin extract fraction (BLPRE), Boswellia volatile oil fraction (BVOIL) or Boswellia oil fraction (BOIL) comprising BLPRE and BVOIL in c...
|
|
WO/2011/121849 |
Disclosed is a production method for a polyamide having a norbornane skeleton. A norbornane dicarboxylic acid compound represented by general formula (I) and a diisocyanate compound are reacted in a polar solvent. Thus, the disclosed nov...
|
|
WO/2011/120778 |
The invention concerns three novel polymorphic forms and several novel salts of 1-(3 ',4'-dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylic acid, and their use in prevention or treatment of Alzheimer's Disease.
|
|
WO/2011/113859 |
A process for preparing [(1R,2R)-4-oxo-1,2-cyclopentanedicarboxylic acid II, by the resolution of racemic 4-oxo-1,2-cyclopentanedicarboxylic acid (V), said process comprising: (a) reacting 4-oxo-1,2-cyclopentanedicarboxylic acid (V) with...
|
|
WO/2011/099112 |
Provided is a technique for a process for the synthesis of acrolein by reacting glycerol with supercritical water and an acid. In a case where a reaction fluid having a high glycerol concentration is employed to improve the energy effici...
|
|
WO/2011/027618 |
Provided are a novel tricyclodecane monomethanol monocarboxylic acid and derivatives thereof which can be employed as starting materials for highly heat-resistant alicyclic polyester or the like. The tricyclodecane monomethanol monocarbo...
|
|
WO/2011/015287 |
The invention relates to a process for the preparation of a compound of formula (IA).
|
|
WO/2011/015287 |
The invention relates to a process for the preparation of a compound of formula (IA).
|
|
WO/2011/006621 |
This invention relates to novel cyclo alkyl compounds suitable for labeling by 18F, methods of preparing such a compound, compositions comprising such compounds, kits comprising such compounds or compositions and uses of such compounds, ...
|
|
WO/2010/150847 |
Disclosed are a dehydroabietic acid polymer having a repeating unit comprising a dehydroabietic acid skeleton derived from dehydroabietic acid and a composite material containing the polymer.
|
|
WO/2010/148081 |
The present invention relates to novel substituted and unsubstituted terephthalic acid and carboxylate derivatives and products prepared therefrom having a significant renewable content. The invention also relates to processes for prepar...
|
|
WO/2010/148049 |
The present invention relates to the isomerization cis,cis and/or cis, trans muconic acid or esters thereof to trans,trans muconic acid or esters thereof and to the esterification of such muconic acids.
|
|
WO/2010/127440 |
The present invention relates to substituted aromatic compounds of Formula (I) and their pharmaceutical uses. Particular aspects of the invention relate to the use of those compounds in the prevention and/or treatment of various diseases...
|
|
WO/2010/123589 |
A method comprising providing a starting composition comprising a polyunsaturated fatty acid, a polyunsaturated fatty ester, a carboxylate salt of a polyunsaturated fatty acid, a polyunsaturated triglyceride, or a mixture thereof; self-m...
|
|
WO/2010/123589 |
A method comprising providing a starting composition comprising a polyunsaturated fatty acid, a polyunsaturated fatty ester, a carboxylate salt of a polyunsaturated fatty acid, a polyunsaturated triglyceride, or a mixture thereof; self-m...
|
|
WO/2010/116990 |
A cage 1, 2, 3, 4-cyclopentanetetracarboxylic acid (1, 3:2, 4)-dianhydride compound represented by formula [1], and a polyimide obtained by condensing the compound with a diamine. With the compound, it is possible to provide a polyimide ...
|
|
WO/2010/105574 |
Preparation method of pimaric acid type resin acid includes the following steps: (1) adding refined resin acid, turpentine or rosin and maleic anhydride at a mass ratio of 1 :0.3-1.5 into a reaction bottle, dissolving them in C1-C10 lowe...
|
|
WO/2010/095604 |
Provided is a manufacturing method for alicyclic tetracarboxylic acids such as bicyclo [3.3.0) octane-2-exo-4-exo-6-endo-8-endo-tetracarboxylic acid of high purity and high producibility. The alicyclic tetracarboxylic acid manufacturing ...
|
|
WO/2010/067824 |
A process for industrially producing an intermediate for a compound that shows an inhibitory action on an activated blood coagulation factor X and that is useful as a preventive and/or therapeutic agent for thrombotic diseases has been d...
|
|
WO/2010/054271 |
This disclosure is directed to the methods of enhancing hematopoietic stem cells (HSPC) and progenitor cell (HSPC) engraftment procedure. Treatment in vivo of a HSPC donor with compounds that reduce PGE2 biosynthesis or PGE2 receptor ant...
|
|
WO/2010/054271 |
This disclosure is directed to the methods of enhancing hematopoietic stem cells (HSPC) and progenitor cell (HSPC) engraftment procedure. Treatment in vivo of a HSPC donor with compounds that reduce PGE2 biosynthesis or PGE2 receptor ant...
|
|
WO/2010/038633 |
Disclosed is a production process which can produce a trans-dicyclohexane derivative in high yield. The production process comprises hydrogenating a specific phenyl-trans-cyclohexane derivative in the presence of a rhodium catalyst to pr...
|
|
WO/2010/030095 |
This invention relates to diol-ester based plasticiser compound, particularly to plasticisers for polyvinyl chloride (PVC), and plastics containing the same. More specifically, this invention relates to plasticisers prepared by esterific...
|
|
WO/2010/030095 |
This invention relates to diol-ester based plasticiser compound, particularly to plasticisers for polyvinyl chloride (PVC), and plastics containing the same. More specifically, this invention relates to plasticisers prepared by esterific...
|
|
WO/2010/026711 |
Disclosed is a new platinum complex, and medical compound containing same, which has strong antineoplastic activity and is efficacious at smaller doses. The platinum complex has a spiro [4,4]nonane-1,6-diamine represented by general form...
|
|
WO/2010/024298 |
Disclosed is a compound represented by formula (I) [wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the description] or a pharmaceutically acceptable salt or solvate thereof.
|
|
WO/2010/012650 |
There is provided novel compounds capable of modulating the G-protein-coupled receptor GPR40, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatment of conditions suc...
|
|
WO/2010/010869 |
A process for producing a hydrogenated aromatic polycarboxylic acid which comprises hydrogenating the aromatic ring of an aromatic polycarboxylic acid in the presence of a catalyst obtained by depositing rhodium and at least one of palla...
|
|
WO/2010/009068 |
The present application describes modulators of MCP-1 or CCR-2 of formula,(I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein T, W, X, Y, Z, R1, R2, R4 and R6, are defined herein. In addition, methods o...
|
|
WO/2010/009068 |
The present application describes modulators of MCP-1 or CCR-2 of formula,(I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein T, W, X, Y, Z, R1, R2, R4 and R6, are defined herein. In addition, methods o...
|
|
WO/2010/005003 |
Disclosed is a method for producing (1S,2R)-2-chloro-2-fluorocyclopropanecarboxylic acid with a high yield and high selectivity. Specifically disclosed is a method for producing (1S,2R)-2-chloro-2-fluorocyclopropanecarboxylic acid, where...
|
|
WO/2009/146659 |
Disclosed is a process for preparing isopimaric acid, comprising the following steps: first step: dissolving thermally isomerized rosin in acetone, adding in drops a solution of isobutanolamine in acetone to form precipitate, standing, f...
|
|
WO/2009/121788 |
A process for the preparation of a compound of formula (Ia): which are useful as intermediates in the preparation of i.a. pharmaceutically active compounds.
|
|
WO/2009/112622 |
The present invention describes a method for producing mero sesquiterpenes, more specifically drimenylbenzenes and drimenylnaphthoquinones, by means of a Diels-Alder reaction between a labdane diterpene and a dienophyl. Subsequently, a...
|
|
WO/2009/089365 |
A highly pure asiaticoside and a pharmaceutical grade asiatic acid can be prepared, along with salts of asiatic acid, for use in formulating therapeutic compositions that are suitable for treating arthritis, psoriasis and other inflammat...
|
|
WO/2009/089365 |
A highly pure asiaticoside and a pharmaceutical grade asiatic acid can be prepared, along with salts of asiatic acid, for use in formulating therapeutic compositions that are suitable for treating arthritis, psoriasis and other inflammat...
|
|
WO/2009/077590 |
The present invention relates to a method for producing 2,2-dichlorocyclopropane carboxylic acid esters, wherein an α,β-unsaturated carboxylic acid ester is reacted with chloroform in the presence of an aqueous alkali metal hydroxide s...
|
